Yogaraja Guggulu in classical Ayurveda

What it is

Yogaraja Guggulu is a guggulu preparation. It comes in tablet form. The formula: 27 herbs in equal parts: Chitraka (Plumbago zeylanica), Pippalimoola (Piper longum root), Yavani (Trachyspermum ammi), Karavi (Piper chaba), Ajamoda, Jeeraka (cumin), Suradaru (Cedrus deodara), Chavya (Piper cubeba), Ela (cardamom), Saindhava lavana (rock salt), Kushta (Saussurea lappa), Rasna (Pluchea lanceolata), Gokshura (Tribulus terrestris), Dhanyaka (coriander), Triphala, Musta (Cyperus rotundus), Trikatu (ginger, black pepper, long pepper), Twak (cinnamon), Usheera (Vetiveria zizanioides), Yavakshara (barley alkali), Taleesapatra (Abies webbiana), Patra (Cinnamomum leaf), plus Vidanga in some versions. These are combined with purified guggulu resin (Commiphora mukul) and ghee, rolled into pills (Eayur; JETIR 2024).

The design logic: guggul resin as the joint-focused base; pungent digestive herbs (trikatu, chitrak, ajwain) to clear ama (metabolic residue); rasna and gokshura as the Vata-pacifying joint herbs; and triphala as the mild cleanser.

Classical properties

• Taste (rasa): bitter (Tikta), pungent (Katu)
• Qualities (guna): light (Laghu), dry (Ruksha)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata; may increase Pitta

Traditional use

Ayurvedic sources describe Yogaraja Guggulu as pungent-bitter, heating (Ushna virya). Its prabhava: Vatahara (Vata-pacifying) and Shothahara (swelling-reducing). Classical indications: Amavata (rheumatoid arthritis), Adhyavata (gout), sciatica, chronic musculoskeletal pain, osteoarthritis, splenomegaly, abdominal tumors (gulma), bloating, piles, and worm infestation. It is said to increase digestion, complexion, strength, and immunity (Eayur; Gita Ayurvedic).

Tradition's testimony above. The laboratory's below. We keep the courtrooms separate.

What research has looked at

Knee osteoarthritis study (human, n=120)

An open-label, multicenter, prospective study enrolled 120 patients aged 35–65 with primary knee osteoarthritis (ACR criteria, radiological changes). They received Yogaraj guggulu, together with Gandharvahasta taila taken orally and Dhanwantara taila applied externally, for 12 weeks. Total WOMAC scores and clinical symptoms reduced significantly from baseline to end of treatment (J Res Ayurvedic Sci 2019).

The measured take: 120 patients with validated outcome measures is the strongest human data available for this formulation. But it was open-label with no control group, and two co-therapies were given. The improvement cannot be attributed to Yogaraja Guggulu alone. Placebo/expectation effects are uncontrolled.

Comparative and preclinical work

A 2024 comparative study tested Agnikarma (thermal cautery) versus Yograja Guggulu in knee osteoarthritis (Janu Sandhigatavata). Both arms were assessed on pain, tenderness, swelling, range of movement, and crepitus (JETIR 2024). In rats, Yogaraja gulgulu showed anti-arthritic activity against Freund's adjuvant-induced paw swelling (J Phytol 2011).

What the evidence does not support (yet)

No blinded, placebo-controlled trial of Yogaraja Guggulu exists. Rheumatoid arthritis, gout, sciatica, and systemic indications are traditional only.

Safety notes

A note on the thyroid. In rats, a guggul extract increased thyroid activity (Tripathi et al. 1988, rat study), animal evidence, not a demonstrated human interaction. People with thyroid disorders or on thyroid medication are still best served using it only under supervision.

Bleeding and surgery. Purified guggul steroids inhibited platelet aggregation in laboratory (in-vitro) work, cell-level evidence, not human studies (Sahni et al., in-vitro). Out of caution, stop before surgery and use carefully with anticoagulants or antiplatelet drugs. The clinical bleeding risk is unquantified.

Skin and GI effects. Guggulu preparations can cause rash, nausea, or loose stools in some people.

During pregnancy. No safety data were identified, and broad use in traditional texts is not evidence of safety, so it belongs only under supervision.

Joint red flags. Hot swollen single joint, fever with joint pain, inability to bear weight, or numbness/weakness down the leg (possible cauda equina) need urgent medical evaluation. Not a guggulu tablet.

FAQs

What is Yogaraja Guggulu?

A classical Ayurvedic joint tablet of purified guggul resin with 27 herbs (chitrak, pippalimoola, trikatu, triphala, rasna, gokshura, devadaru, and others). It is traditionally used for arthritis, gout, and sciatica (Eayur).

Does it work for knee osteoarthritis?

A 120-patient open-label study found significant WOMAC improvement over 12 weeks. But with no control group and two co-therapies, the result is suggestive, not conclusive (J Res Ayurvedic Sci 2019).

How is it taken?

As tablets, traditionally after food. Product labels give their own directions (Gita Ayurvedic), but Swastik does not suggest amounts: follow a qualified practitioner.

Is it safe with thyroid medication?

Animal evidence suggests guggul can stimulate thyroid activity. No human interaction study exists. Discuss with your doctor. This is a real concern to check, not an established interaction.

Why is there no formal dosage section in this article?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Sources

The composition (27 herbs in equal parts; purified guggulu; ghee; pills) and traditional indications (Amavata/rheumatoid arthritis, Adhyavata/gout, krumi, dushta vrana, pleeha, gulma, anaha) are Eayur (page) and the JETIR 2024 comparative study (PDF). The knee-OA study (n=120, with two oils, 12 weeks, WOMAC reduced significantly) is the Journal of Research in Ayurvedic Sciences 2019 (abstract). The rat adjuvant-arthritis study is J Phytol 2011 (PDF).

Disclaimer

This article is for educational purposes only and is not medical advice. Yogaraja Guggulu has no blinded, placebo-controlled trial evidence; the best human data is an uncontrolled open-label study with co-therapies. Animal and laboratory evidence suggests possible effects on thyroid function and platelet aggregation, but neither is established in humans — discuss with a doctor if you take thyroid, anticoagulant, or antiplatelet medication, or are pregnant. Joint red flags (hot swollen joint, fever, inability to bear weight, leg numbness/weakness) need urgent medical care. Talk to a qualified healthcare practitioner before use.